• Mechthild Westhoff-Bleck, Bernhard Schieffer, Uwe Tegtbur, Gerd Peter Meyer, Ludwig Hoy, Arnd Schaefer, Ezequiel Marcello Tallone, Oktay Tutarel, Ramona Mertins, Lena Mara Wilmink, Stefan D Anker, Johann Bauersachs, and Philipp Roentgen.
• Department of Cardiology and Angiology, Hannover Medical School, Germany. Electronic address: Westhoff-Bleck.Mechthild@MH-Hannover.de.
• Int. J. Cardiol. 2013 Dec 5; 170 (1): 24-9.

BackgroundExercise training safely and efficiently improves symptoms in patients with heart failure due to left ventricular dysfunction. However, studies in congenital heart disease with systemic right ventricle are scarce and results are controversial. In a randomised controlled study we investigated the effect of aerobic exercise training on exercise capacity and systemic right ventricular function in adults with d-transposition of the great arteries after atrial redirection surgery (28.2 ± 3.0 years after Mustard procedure).Methods48 patients (31 male, age 29.3 ± 3.4 years) were randomly allocated to 24 weeks of structured exercise training or usual care. Primary endpoint was the change in maximum oxygen uptake (peak VO2). Secondary endpoints were systemic right ventricular diameters determined by cardiac magnetic resonance imaging (CMR). Data were analysed per intention to treat analysis.ResultsAt baseline peak VO2 was 25.5 ± 4.7 ml/kg/min in control and 24.0 ± 5 ml/kg/min in the training group (p=0.3). Training significantly improved exercise capacity (treatment effect for peak VO2 3.8 ml/kg/min, 95% CI: 1.8 to 5.7; p=0.001), work load (p=0.002), maximum exercise time (p=0.002), and NYHA class (p=0.046). Systemic ventricular function and volumes determined by CMR remained unchanged. None of the patients developed signs of cardiac decompensation or arrhythmias while on exercise training.ConclusionsAerobic exercise training did not detrimentally affect systemic right ventricular function, but significantly improved exercise capacity and heart failure symptoms. Aerobic exercise training can be recommended for patients following atrial redirection surgery to improve exercise capacity and to lessen or prevent heart failure symptoms. (Clinical Trial RegistrationClinicalTrials.gov #NCT00837603).© 2013.

18 keywords...

hide…